Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
Available to download in languages
1990 results found
2024 ∙ NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
  • Older adults
  • Recommendation
  • Canada
  • COVID-19
Download:
2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
  • Acceptance
  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Tetanus
Rating:
Not applicable
2023 ∙ Xu, K. Wang, Z. Qin, M. Gao, Y. Luo, N. Xie, W. Zou, Y. Wang, J. Ma, X.
A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • Safety
  • Adults
  • Older adults
  • COVID-19
Rating:
Critically low
2023 ∙ Tavabe, Nilay Rezaei Kheiri, Soleiman Dehghani, Mohsen Mohammadian-Hafshejani, Abdollah
A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly
  • Efficacy/effectiveness
  • Older adults
  • Influenza
Rating:
Critically low
2023 ∙ Chen, S. Wei, W. Huang, F. Wang, J. Li, X. Gen, Z. Gao, F. Dong, T. Wei, P. Yang, X. Miao, F.
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
  • Vaccine/vaccination
  • Safety
  • Efficacy/effectiveness
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Mohammed, H. Pham-Tran, D. D. Yeoh, Z. Y. M. Wang, B. McMillan, M. Andraweera, P. H. Marshall, H. S.
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • All age groups
  • Healthcare workers
  • COVID-19
Rating:
Critically low
2023 ∙ Whitehead, H. S. French, C. E. Caldwell, D. M. Letley, L. Mounier-Jack, S.
A systematic review of communication interventions for countering vaccine misinformation
  • Vaccine/vaccination
  • Acceptance
  • All age groups
  • Parents/caregivers
  • COVID-19
Rating:
Not applicable
2023 ∙ Ayyalasomayajula, S. Dhawan, A. Karattuthodi, M. S. Thorakkattil, S. A. Abdulsalim, S. Elnaem, M. H. Sridhar, S. Unnikrishnan, M. K.
A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population
  • Vaccine/vaccination
  • Acceptance
  • Adults
  • Older adults
  • COVID-19
Rating:
Not applicable
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • Safety
  • Adults
  • Older adults
  • Saudi Arabia
  • COVID-19
Rating:
Critically low
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Economic aspects
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
Rating:
Not applicable